Showing results (1061-1070 of 1,334) with videos related to

Sort By:
Pageof 134
Health Research Policy and Systems|September 18, 2020
Transforming the practice of medicine through team scienceJason H Pitzen, Heidi L Dieter, Darren L Gronseth, et al.
The Journal of Experimental Biology|December 16, 2005
Packaging of chemicals in the defensive secretory glands of the sea hare Aplysia californicaPaul M Johnson, Cynthia E Kicklighter, Manfred Schmidt, et al.
Physics in Medicine and Biology|August 31, 2002
HeinzelCluster: accelerated reconstruction for FORE and OSEM3DS Vollmar, C Michel, J T Treffert, et al.
Clinical Pharmacology and Therapeutics|May 1, 1996
Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphanJ P Kévorkian, C Michel, U Hofmann, et al.
Pharmacological Reviews|March 14, 2023
Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related DisordersMartin C Michel, Linda Cardozo, Christopher J Chermansky, et al.
Blood|July 7, 2011
In vitro efficacy of forodesine and nelarabine (ara-G) in pediatric leukemiaIrene Homminga, C Michel Zwaan, Chantal Y Manz, et al.
Circulation|February 1, 1993
Direct comparison of [13N]ammonia and [15O]water estimates of perfusion with quantification of regional myocardial blood flow by microspheresA Bol, J A Melin, J L Vanoverschelde, et al.
The American Journal of Physiology|December 1, 1994
Skeletal muscle phosphate metabolism abnormalities in volume-overload experimental heart failureZ Chati, F Zannad, C Michel, et al.
European Journal of Pharmacology|October 14, 1994
[Pro34]peptide YY is a Y1-selective agonist at peptide YY/neuropeptide Y receptorsD Grandt, F Feth, W Rascher, et al.
Acta Paediatrica (Oslo, Norway : 1992)|March 19, 2016
Participation in a clinical trial for a child with cancer is burdensome for a minority of childrenIvana M M van der Geest, Marry M van den Heuvel-Eibrink, C Michel Zwaan, et al.
Pageof 134